Sustained Release Formulation of Somatropin (rDNA Origin)for Injection
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
Annualised height velocity after 12/24 months treatment and HV SDS height velocity after
12/24 months treatment expressed as number of standard deviations difference from the mean
population height velocity for the appropriate gender and chronological age.